Murat Çelik

Murat Çelik

Auto-generated profile, based on publicly available information

Murat Çelik

Department of Cardiology, Gülhane Faculty of Medicine, University of Health Sciences, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
EYErkan Yildirim Yildirim
Erkan Yildirim Yildirim
MCMurat Celik
Murat Celik
UYUygar Cagdas Yuksel
Uygar Cagdas Yuksel
MGMutlu Gungor
Mutlu Gungor
BBBaris Bugan
Baris Bugan
CBCem Barcin
Cem Barcin
Yildirim E, et al. Korean Circ J. 2017 Nov;47(6):929-938. https://doi.org/10.4070/kcj.2017.0081

1 January 2023 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
VOVeysel Oktay
Veysel Oktay
OTOmaç Tüfekçioğlu
Omaç Tüfekçioğlu
DYDilek Çicek Yılmaz
Dilek Çicek Yılmaz
EOErsel Onrat
Ersel Onrat
DKDilay Karabulut
Dilay Karabulut
HOHüseyin Onay
Hüseyin Onay
Hypertrophic cardiomyopathy is a common genetic heart disease and up to 40%-60% of patients have mutations in cardiac sarcomere protein genes. This genetic diagnosis study aimed to detect pathogenic or likely pathogenic sarcomeric and non-sarcomeric gene mutations and to confirm a final molecular diagnosis in patients diagnosed with hypertrophic cardiomyopathy. A total of 392 patients with hypertrophic cardiomyopathy were included in this nationwide multicenter study conducted at 23 centers across Türkiye. All samples were analyzed with a 17-gene hypertrophic cardiomyopathy panel using next-generation sequencing technology. The gene panel includes ACTC1, DES, FLNC, GLA, LAMP2, MYBPC3, MYH7, MYL2, MYL3, PLN, PRKAG2, PTPN11, TNNC1, TNNI3, TNNT2, TPM1, and TTR genes. The next-generation sequencing panel identified positive genetic variants (variants of unknown significance, likely pathogenic or pathogenic) in 12 genes for 121 of 392 samples, including sarcomeric gene mutations in 30.4% (119/392) of samples tested, galactosidase alpha variants in 0.5% (2/392) of samples and TTR variant in 0.025% (1/392). The likely pathogenic or pathogenic variants identified in 69 (57.0%) of 121 positive samples yielded a confirmed molecular diagnosis. The diagnostic yield was 17.1% (15.8% for hypertrophic cardiomyopathy variants) for hypertrophic cardiomyopathy and hypertrophic cardiomyopathy phenocopies and 0.5% for Fabry disease. Our study showed that the distribution of genetic mutations, the prevalence of Fabry disease, and TTR amyloidosis in the Turkish population diagnosed with hypertrophic cardiomyopathy were similar to the other populations, but the percentage of sarcomeric gene mutations was slightly lower.

SASerkan Asil
Serkan Asil
EMEnder Murat
Ender Murat
HTHatice Taşkan
Hatice Taşkan
VBVeysel Barış
Veysel Barış
SGSuat Görmel
Suat Görmel
CBCem Barçın
Cem Barçın
Introduction: The most important way to reduce CVD-related mortality is to apply appropriate treatment according to the risk status of the patients. For this purpose, the SCORE risk model is used in Europe. In addition to these risk models, some anthropometric measurements are known to be associated with CVD risk and risk factors. Objectives: This study aimed to investigate the association of these anthropometric measurements, especially neck circumference (NC), with the SCORE risk chart. Methods: This was planned as a cross-sectional study. The study population were classified according to their SCORE risk values. The relationship of NC and other anthropometric measurements with the total cardiovascular risk indicated by the SCORE risk was investigated. Results: A total of 232 patients were included in the study. The patients participating in the study were analysed in four groups according to the SCORE ten-year total cardiovascular mortality risk. As a result, the NC was statistically significantly lower among the SCORE low and moderate risk group than all other SCORE risk groups (low-high and very high 36(3)–38(4) (IQR) p: 0.026, 36(3)–39(4) (IQR) p < 0.001, 36(3)–40(4) (IQR) p < 0.001), (moderate-high and very high 38(4) vs. 39(4) (IQR) p: 0.02, 38(4) vs. 40(4) (IQR) p < 0.001, 39(4) vs. 40(4) (IQR) p > 0.05). NC was found to have the strongest correlation with SCORE than the other anthropometric measurements. Conclusions: Neck circumference correlates strongly with the SCORE risk model which shows the ten-year cardiovascular mortality risk and can be used in clinical practice to predict CVD risk.

1 December 2013
Verified
Open access
PDF file
MCMurat Celik
Murat Celik
UYUygar Cagdas Yuksel
Uygar Cagdas Yuksel
EYEmre Yalcinkaya
Emre Yalcinkaya
YGYalcin Gokoglan
Yalcin Gokoglan
AIAtila Iyisoy
Atila Iyisoy
Conservative treatment of iatrogenic left main coronary artery dissection: report of two cases

5 December 2013 in Echocardiography
Verified
Journal Article
Closed access
PDF file
MCMurat Celik
Murat Celik
UYUygar Cagdas Yuksel
Uygar Cagdas Yuksel
EYEmre Yalcinkaya
Emre Yalcinkaya
YGYalcin Gokoglan
Yalcin Gokoglan
EYErkan Yildirim
Erkan Yildirim
MGMutlu Gungor
Mutlu Gungor

1 September 2016 in Turkish Journal of Emergency Medicine
Verified
Journal Article
Open access
SYSalim Yasar
Salim Yasar
EYErkan Yildirim
Erkan Yildirim
MKMustafa Koklu
Mustafa Koklu
EGErol Gursoy
Erol Gursoy
MCMurat Celik
Murat Celik
UYUygar Cagdas Yuksel
Uygar Cagdas Yuksel
Inhalation of toluene-based products is popular among young adults. It has been shown to have a variety of adverse effects on several organs and systems. Although the heart seems to be a sensitive target organ to toluene, cardiotoxicity has often been ignored, especially in cases of acute toluene abuse, with relatively low concentrations. Thereby, routine cardiac examination and echocardiography for cardiotoxicity should be performed in cases of acute toluene exposure, even though there is no cardiovascular sign or symptoms.